Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Cholangiocarcinoma × Clinical Protocols × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Leukemia, Myeloid, Acute 4 Paraproteinemias 2 Immunoglobulin Light-chain Amyloidosis 2 Breast Neoplasms 2 Uterine Neoplasms 1 Uterine Cervical Neoplasms 1 Stomach Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Recurrence 1 Pneumonia 1 Papillomavirus Infections 1 Pancreatic Neoplasms 1 Osteosarcoma 1 Neoplasms, Plasma Cell 1 Neoadjuvant Therapy in Rectal Cancer, Radiotherapy, FOLFOX 1 Myelodysplastic Syndromes 1 Multiple Myeloma 1 Lymphoma, T-Cell 1 Lymphoma, Extranodal NK-T-Cell 1 Lymphoma, B-Cell 1 Lung Neoplasms 1 Lung Diseases, Interstitial 1 Locally Advanced Breast Cancer 1 Hepatitis 1 Fibrosis 1 Endometrial Neoplasms 1 Colorectal Neoplasms 1 Cholangiocarcinoma 1 Carcinoma, Non-Small-Cell Lung 1 Carcinoma, Hepatocellular 1

Interventions

Gemcitabine 95 Cisplatin 63 Oxaliplatin 40 pembrolizumab 30 Fluorouracil 29 Capecitabine 28 lenvatinib 24 durvalumab 24 Leucovorin 23 Nivolumab 11 Magnetic Resonance Spectroscopy 11 Irinotecan 11 Radiotherapy 10 Drug Therapy 10 pemigatinib 9 apatinib 9 Radiofrequency Ablation 9 Albumin-Bound Paclitaxel 9 tislelizumab 8 Taxes 8 Specimen Handling 8 Folfox protocol 8 Floxuridine 8 Biopsy 8 Bevacizumab 8 Liver Transplantation 7 Cholangiopancreatography, Endoscopic Retrograde 7 Carboplatin 7 130-nm albumin-bound paclitaxel 7 tremelimumab 6

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05557578 2025-02-11

GOT

Zhejiang Cancer Hospital

Phase 2 Recruiting

Gastrointestinal

Cholangiocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡